| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Gamma-aminobutyric acid receptor subunit alpha-3 |
|---|
| Ligand | BDBM50608939 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_2275508 |
|---|
| Ki | 5.0±n/a nM |
|---|
| Citation |  Beato, A; Gori, A; Boucherle, B; Peuchmaur, M; Haudecoeur, R ?-Carboline as a Privileged Scaffold for Multitarget Strategies in Alzheimer's Disease Therapy. J Med Chem64:1392-1422 (2021) [PubMed] |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Gamma-aminobutyric acid receptor subunit alpha-3 |
|---|
| Name: | Gamma-aminobutyric acid receptor subunit alpha-3 |
|---|
| Synonyms: | GABA A Alpha3Beta3Gamma2 | GABA A receptor alpha-3/beta-2/gamma-2 | GABA C | GABA receptor alpha-3 subunit | GABA-A receptor | GABRA3 | GBRA3_HUMAN | Gamma-aminobutyric acid receptor subunit alpha-3 | agonist GABA site |
|---|
| Type: | Enzyme Catalytic Domain |
|---|
| Mol. Mass.: | 55175.47 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | GABA A Alpha3Beta1Gamma2 0 HUMAN::P34903 |
|---|
| Residue: | 492 |
|---|
| Sequence: | MIITQTSHCYMTSLGILFLINILPGTTGQGESRRQEPGDFVKQDIGGLSPKHAPDIPDDS
TDNITIFTRILDRLLDGYDNRLRPGLGDAVTEVKTDIYVTSFGPVSDTDMEYTIDVFFRQ
TWHDERLKFDGPMKILPLNNLLASKIWTPDTFFHNGKKSVAHNMTTPNKLLRLVDNGTLL
YTMRLTIHAECPMHLEDFPMDVHACPLKFGSYAYTTAEVVYSWTLGKNKSVEVAQDGSRL
NQYDLLGHVVGTEIIRSSTGEYVVMTTHFHLKRKIGYFVIQTYLPCIMTVILSQVSFWLN
RESVPARTVFGVTTVLTMTTLSISARNSLPKVAYATAMDWFIAVCYAFVFSALIEFATVN
YFTKRSWAWEGKKVPEALEMKKKTPAAPAKKTSTTFNIVGTTYPINLAKDTEFSTISKGA
APSASSTPTIIASPKATYVQDSPTETKTYNSVSKVDKISRIIFPVLFAIFNLVYWATYVN
RESAIKGMIRKQ
|
|
|
|---|
| BDBM50608939 |
|---|
| n/a |
|---|
| Name | BDBM50608939 |
|---|
| Synonyms: | CHEMBL5266498 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C16H16N2O3 |
|---|
| Mol. Mass. | 284.3098 |
|---|
| SMILES | CCOC(=O)c1ncc2[nH]c3ccccc3c2c1COC |
|---|
| Structure | 
|
|---|
Search and Browse
